Correlation Between Hemoglobin Levels and Polycystic Ovary Syndrome Metabolic Disorder

References

• Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071–e1083. doi:10.1210/clinem/dgaa839
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale Héctor F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284. doi:10.1038/nrendo.2018.24
   PubMed Web of Science ®Google Scholar
• Li R, Yu G, Yang D, et al. Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross-sectional study. BMC Endocr Disord. 2014;14(1):1–8. doi:10.1186/1472-6823-14-76
   PubMedGoogle Scholar
• Gell DA. Structure and function of haemoglobins. Blood Cells Mol Dis. 2018;70:13–42.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Tanaka M, Kimura T, et al. Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study. Endocrine. 2015;50(2):390–396. doi:10.1007/s12020-015-0587-9
   PubMed Web of Science ®Google Scholar
• Ahmadzadeh J, Mansorian B, Attari MMA, et al. The association between hematological parameters and metabolic syndrome in Iranian men: a single center large-scale study. Diabetes Metab Syndr. 2018;12(1):17–21. doi:10.1016/j.dsx.2017.07.044
   PubMed Web of Science ®Google Scholar
• He S, Gu H, Yang J, et al. Hemoglobin concentration is associated with the incidence of metabolic syndrome. BMC Endocr Disord. 2021;21(1):1–11. doi:10.1186/s12902-021-00719-4
   PubMed Web of Science ®Google Scholar
• Tanaka M, Okada H, Hashimoto Y, et al. Combined effect of hemoglobin and mean corpuscular volume levels on incident metabolic syndrome: a population-based cohort study. Clin Nutr ESPEN. 2020;40:314–319. doi:10.1016/j.clnesp.2020.08.010
   PubMed Web of Science ®Google Scholar
• Cabrales P, Han G, Nacharaju P, Friedman AJ, Friedman JM. Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol. 2011;300(1):H49–H56. doi:10.1152/ajpheart.00665.2010
   PubMed Web of Science ®Google Scholar
• Facchini FS, Carantoni M, Jeppesen J, Reaven GM. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism. 1998;47(7):831–835. doi:10.1016/S0026-0495(98)90121-4
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Retnakaran R, Qi Y, et al. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab. 2009;94(10):3824–3832. doi:10.1210/jc.2009-0719
   PubMed Web of Science ®Google Scholar
• ESHRE T R, ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
   Web of Science ®Google Scholar
• Metabolic Syndrome Research Cooperative Group of Chinese Diabetes Society. Recommendations of Chinese Diabetes Society on metabolic syndrome. Chin J Diabetes. 2004;3:5–10.
   Google Scholar
• Sun L, Wang GX, Guo YY. Research progress of hyperuricemia. Chin J Gerontol. 2017;37(4):1034–1038.
   Google Scholar
• Wan XH, Lu X. Diagnostics. 9th ed. Beijing: People’s Medical Publishing House; 2018:237–241.
   Google Scholar
• Qiao B, Sugianto P, Fung E, et al. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 2012;15(6):918–924. doi:10.1016/j.cmet.2012.03.018
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez M, Alvarez-Blasco F, Alpanes M, et al. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(3):846–852. doi:10.1210/jc.2010-2211
   PubMed Web of Science ®Google Scholar
• Kahal H, Kyrou I, Uthman OA, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020;24(1):339–350. doi:10.1007/s11325-019-01835-1
   PubMed Web of Science ®Google Scholar
• Song Y, He X, Hu K. Clinical features and risk factors of polycystic ovary syndrome complicated with obstructive sleep apnea. J Clin Pulm Med. 2022;27(06):822–828.
   Google Scholar
• Feliciano A, Vaz F, Valentim-Coelho C, et al. Evening and morning alterations in Obstructive Sleep Apnea red blood cell proteome. Data Brief. 2017;11:103–110. doi:10.1016/j.dib.2017.01.005
   PubMedGoogle Scholar
• Bi YW, Li NF, Yao XG, et al. Changes of hemoglobin in patients with obstructive sleep apnea-hypopnea syndrome. Chin J Hypertens. 2021;29(02):176–179.
   Google Scholar
• Zhang X-B, Zeng Y-M, Zeng H-Q, Zhang H-P, Wang H-L. Erythropoietin levels in patients with sleep apnea: a meta-analysis. Eur Archiv Oto Rhino Laryngol. 2017;274(6):2505–2512. doi:10.1007/s00405-017-4483-1
   PubMed Web of Science ®Google Scholar
• Qiang S, Long K, Ke LH, Liang K, Zhang HY. Relationship between red blood cell distribution width and polycystic ovary syndrome. J Clin Transfus Lab Med. 2021;23(06):779–782.
   Google Scholar
• Yilmaz Ö, Mehmet C, Kelekci S, et al. Association between red blood cell distribution width and polycystic ovary syndrome. Endocr Res. 2015;40(4):181–187. doi:10.3109/07435800.2014.987398
   PubMed Web of Science ®Google Scholar
• Kelly CCJ, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–2455. doi:10.1210/jcem.86.6.7580
   PubMed Web of Science ®Google Scholar
• Yang DY, Quan WQ, Sun ZJ, et al. Research progress in RDW for the diagnosis and treatment of malignant tumors. Lab Med. 2018;33(09):844–849.
   Google Scholar
• Behboudi‐Gandevani S, Amiri M, Bidhendi Yarandi R, et al. The risk of metabolic syndrome in polycystic ovary syndrome: a systematic review and meta‐analysis. Clin Endocrinol. 2018;88(2):169–184. doi:10.1111/cen.13477
   PubMed Web of Science ®Google Scholar
• Li Y, Chen C, Ma Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167–175. doi:10.1016/j.lfs.2019.04.046
   PubMed Web of Science ®Google Scholar
• Ha LX, Yin T, Wu YY, Li WX, Du YD. Correlation between insulin resistance and expressions of local inflammatory factors and glucose transporter protein type-4 in the endometrium of patients with polycystic ovary syndrome. J Shandong Univ. 2021;59(11):41–47.
   Google Scholar
• Shimizu Y, Nakazato M, Sekita T, et al. Association between the hemoglobin levels and hypertension in relation to the BMI status in a rural Japanese population: the Nagasaki Islands Study. Inter Med. 2014;53(5):435–440. doi:10.2169/internalmedicine.53.1353
   PubMed Web of Science ®Google Scholar
• Legro Richard S, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592. doi:10.1210/jc.2013-2350
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim J, Osborne O, et al. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339–1352. doi:10.1016/j.cell.2014.05.012
   PubMed Web of Science ®Google Scholar
• Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1175–1180. doi:10.1210/jcem.86.3.7316
   PubMed Web of Science ®Google Scholar
• Gopal M, Duntley S, Uhles M, Attarian H. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med. 2002;3(5):401–404. doi:10.1016/S1389-9457(02)00033-3
   PubMedGoogle Scholar
• Li J, Zou CC. Research progress on the relationship between CD40-CD40L system and metabolic syndrome. Int J Pediatr. 2017;44(11):791–794.
   Google Scholar
• Kawamoto R, Tabara Y, Kohara K, et al. Hemoglobin is associated with serum high molecular weight adiponectin in Japanese community-dwelling persons. J Atheroscler Thromb. 2011;18(3):182–189. doi:10.5551/jat.6379
   PubMed Web of Science ®Google Scholar
• Li J, Xu J, Zou CC, et al. Association between CD40-CD40L system and obesity in children. Chin J Contemp Pediatr. 2020;22(3):251–256. doi:10.7499/j.issn.1008-8830.2020.03.013
   Google Scholar
• Kutlu M, Sonmez A, Genc H, et al. Relationship between hemoglobin and CD40 ligand in prediabetes. Clin Invest Med. 2009;32(6):E244–E250. doi:10.25011/cim.v32i6.10659
   PubMed Web of Science ®Google Scholar
• Qiao J, Qi XY, Xu YL, et al. Pay attention to important reproductive endocrinologic diseases affecting female health-polycystic ovary syndrome. Chin J Pract Gynecol Obstetr. 2020;36(1):1–9.
   Google Scholar
• Kawamoto R, Tabara Y, Kohara K, et al. Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons. Endocrine. 2013;43(2):334–341. doi:10.1007/s12020-012-9662-7
   PubMed Web of Science ®Google Scholar
• He SY, Lu S, Gu HX, et al. Association of hemoglobin level with type 2 diabetes in middle-aged and elderly population in Shanghai Chongming District. Chin J Diabetes. 2020;12(05):297–304.
   Google Scholar
• Sonmez A, Yilmaz MI, Saglam M, et al. The relationship between hemoglobin levels and endothelial functions in diabetes mellitus. Clin J Am Soc Nephrol. 2010;5(1):45–50. doi:10.2215/CJN.05080709
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen Q, Yuan Z, et al. A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population. BMC Public Health. 2015;15(1):1–9. doi:10.1186/s12889-015-1424-z
   PubMedGoogle Scholar
• Assumpção CRL, Brunini TMC, Pereira NR. Insulin resistance in obesity and metabolic syndrome: is there a connection with platelet l-arginine transport? Blood Cells Mol Dis. 2010;45(4):338–342. doi:10.1016/j.bcmd.2010.10.003
   PubMed Web of Science ®Google Scholar
• Moan A, Nordby G, Os I, et al. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism. 1994;43(4):423–427. doi:10.1016/0026-0495(94)90070-1
   PubMed Web of Science ®Google Scholar
• Zhang YL, Li XL. Value of serum ferritin, hemoglobin, and glycosylated hemoglobin during the first and the second trimester of pregnancy for predicting their risk of gestational diabetes mellitus. Chin J Fam Plan. 2021;29(7):1502–1506.
   Google Scholar
• Shan ZM, Xia XH, Qian XH, et al. The research on the correlation between male metabolic syndrome and erythrocyte parameters. Zhejiang Med Educ. 2016;15(2):58–60.
   Google Scholar
• Miyagawa S, Kobayashi M, Konishi N, Sato T, Ueda K. Insulin and insulin‐like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors. Br J Haematol. 2000;109(3):555‐562. doi:10.1046/j.1365-2141.2000.02047.x
   PubMed Web of Science ®Google Scholar
• Aoki I, Taniyama M, Toyama K, Homori M, Ishikawa K. Stimulatory effect of human insulin on erythroid progenitors (CFU‐E and BFU‐E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin. Stem Cells. 1994;12(3):329‐338. doi:10.1002/stem.5530120309
   PubMed Web of Science ®Google Scholar
• Wang GL, Semenza GL. Molecular basis of hypoxia‐induced erythropoietin expression. Curr Opin Hematol. 1996;3(2):156‐162. doi:10.1097/00062752-199603020-00009
   PubMedGoogle Scholar
• Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia‐inducible factor 1. Annu Rev Cell Dev Biol. 1999;15(1):551‐578. doi:10.1146/annurev.cellbio.15.1.551
   PubMedGoogle Scholar